Carderock Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$1.29M |
| 2 |
Clorox
CLX
|
+$683K |
| 3 |
Keurig Dr Pepper
KDP
|
+$583K |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$563K |
| 5 |
Fastenal
FAST
|
+$462K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$1.96M |
| 2 |
W.W. Grainger
GWW
|
+$1.37M |
| 3 |
O'Reilly Automotive
ORLY
|
+$1.28M |
| 4 |
AbbVie
ABBV
|
+$1.24M |
| 5 |
IBM
IBM
|
+$1.16M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.01% |
| 2 | Healthcare | 18.16% |
| 3 | Industrials | 17.15% |
| 4 | Consumer Discretionary | 7.52% |
| 5 | Financials | 6.9% |
Similar funds
Carderock Capital Management's Q3 2013 Portfolio in Review
As of Q3 2013, Carderock Capital Management held 93 positions worth $172M, up 1.9% from $169M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Carderock Capital Management withdrew a net $8.22M in Q3 2013, closing 4 positions and reducing 41 holdings. Its most notable exit was Southern Company, an estimated $868K position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Carderock Capital Management opened a new position in Clorox worth $661K.
- Carderock Capital Management's largest Q3 2013 buy was Clorox: 8,090 shares worth $661K.
- Carderock Capital Management added most to Accenture in Q3 2013, an estimated $1.29M increase.
- Carderock Capital Management's biggest Q3 2013 reduction was Express Scripts Holding Company, cutting an estimated $1.96M.
- Carderock Capital Management fully exited Southern Company in Q3 2013, selling an estimated $868K.
- Carderock Capital Management's ten largest holdings make up 28% of its $172M portfolio in Q3 2013.
- Carderock Capital Management opened 6 new positions and closed 4 in Q3 2013.
- Carderock Capital Management's portfolio value rose 1.9% quarter-over-quarter to $172M.
Based on Carderock Capital Management's 13F filing for Q3 2013, filed 14 Nov 2013.